Inpeco SA and Pinnacles Medical establish Joint Venture for Production and Commercialization in China
The new Jiangyin facility will manufacture FlexLab™ X for the Chinese market and will serve as a logistics hub for the Asia-Pacific region.
Novazzano, Switzerland – [11.09.2025] – Inpeco, the global leader in Total Laboratory Automation (TLA), today announced the signing of a partnership agreement with Pinnacles Medical to establish a joint venture to manufacture and commercialize Inpeco’s solutions in China.
The new production facility will be located in Jiangyin 121 Research Park in the Yangtze River Delta, one of China’s most advanced industrial and healthcare innovation corridors.
With more than 600 systems installed across China, Inpeco has a well-established presence in the country. The Jiangyin facility represents a milestone in the company’s “in China for China” strategy that will enable localized production of its latest-generation FlexLab™ X system while also serving as a logistics and innovation hub for the Asia-Pacific region.
“China is a cornerstone of Inpeco’s global growth strategy,” said Riccardo Triunfo, CEO of Inpeco. “We are not just investing in local manufacturing—we are investing in a new vision for automation in China. Our goal is to accelerate the transition from closed, siloed systems to a new standard of openness, flexibility, and interoperability. We are proud to establish our production base in Jiangyin, a region known for industrial excellence and strategic connectivity. We thank the local government for their outstanding support and are confident that our partnership with Pinnacles Medical—covering both manufacturing and commercialization—will unlock new value for healthcare providers across China.”
This joint venture also advances the partners’ shared vision of Super-TLA: a fully open and modular automation platform that connects all analytical instruments—domestic or international—within a unified, traceable workflow. This vendor-neutral approach enables laboratories to design their ideal ecosystem, without compromise.
Richard Ding, Founder and CEO of Pinnacles Medical, commented: “The launch of our joint venture aligns with Pinnacle’s strategic vision and will significantly advance smart laboratory testing. By locally manufacturing Inpeco’s FlexLab™ X system, we are bringing world-leading automation technology into China’s healthcare landscape. This will greatly enhance product delivery efficiency and enable rapid responses to the personalized needs of medical institutions at all levels. And it marks a concrete step toward aligning China’s laboratory automation standards with international benchmarks.”
The project’s successful execution in record time also reflects the dedication and collaboration of the teams involved. “I feel privileged to have led an extraordinary group of professionals whose talent, commitment, and teamwork made this achievement possible. Throughout the process, we not only built strong relationships with our partners in China, but also gained valuable market insights. It has been a great experience to see this vision turn into reality,” said Riccardo Mazzolai, Inpeco Enterprise Program Manager.
“This production base is a concrete step toward realizing Inpeco’s vision of fully automated, error-free diagnostic processes,” said Gian Andrea Pedrazzini, Founder of Inpeco. “End-to-end automation—from sample collection to result delivery—not only improves accuracy and efficiency, but lays the foundation for the future of diagnostics.”
“We believe that laboratory automation is a key enabler of the 4P model of medicine—Predictive, Preventive, Personalized, and Participatory. By eliminating variability and ensuring full sample traceability, our systems provide the reliability and consistency that next-generation healthcare demands.”
About Inpeco
Inpeco is the global leader in Total Laboratory Automation. The company’s game-changing solutions combine open connectivity with full sample traceability to support secure test results and increase productivity in clinical laboratories around the world. To date, more than 2800 Inpeco systems have been shipped to 78 countries. Inpeco also provides automation for anatomical pathology labs and is developing solutions for blood banks and life sciences applications. The Group is headquartered in Novazzano, Switzerland, and operates a development and manufacturing facility in Italy, as well as sales offices in Europe, China, and the United States.
For more information, please visit: www.inpeco.com
About Pinnacles
PINNACLES is committed to building more complete and truly intelligent medical testing laboratories, continuously enriching PINNACLES’s smart testing ecosystem to achieve automation, intelligence, and smartization of the entire testing process from sample to result. In the future, PINNACLES will rely on its advantages in major sectors, new products, strong teams, and superior ecosystems to establish the image of a new top-tier domestic IVD brand, achieving breakthroughs from import substitution to surpassing imported products.
“Quality as Solid as Mountains, Aspirations Beyond Peaks.” PINNACLES will adhere to its original aspirations, with product innovation at the core and customer service as its purpose, to create a new future for China’s healthcare industry.